Company intelligence / Profile preview

Compound Ventures

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Compound, also referred to as Compound Ventures, is a New York-based early-stage venture capital and research-driven investment firm rather than a biotechnology, pharmaceutical, or healthcare operating company. The firm invests across deeply technical sectors including biology, health, crypto, AI/ML, robotics, climate, industrials, and frontier technology. Its role is to back and help commercialize portfolio companies, not to develop therapeutic products or run its own clinical pipeline. Although Compound has invested in bio and health companies and publishes research in biology-related areas, it is not itself a life sciences developer.

Industry: Investors

Beyond the preview

Go deeper on Compound Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Ventures.

Explore the full profile